Rohit Bhargava Selected Research

2,4,5-trimethoxyphenylisopropylamine (TMA-2)

11/2009	PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
11/2008	CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rohit Bhargava Research Topics

Disease

70	Neoplasms (Cancer) 11/2022 - 05/2004
69	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2004
17	Carcinoma (Carcinomatosis) 05/2021 - 04/2006
8	Pathologic Complete Response 04/2022 - 01/2009
7	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2006
4	Triple Negative Breast Neoplasms 04/2022 - 11/2015
4	Liver Neoplasms (Liver Cancer) 01/2022 - 10/2017
4	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2015 - 11/2006
3	Necrosis 11/2020 - 02/2010
3	Papillary Carcinoma 01/2020 - 02/2009
3	Lobular Carcinoma 07/2011 - 03/2007
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 10/2021 - 07/2008
2	Adenocarcinoma 10/2017 - 02/2013
2	Brain Neoplasms (Brain Tumor) 05/2017 - 10/2015
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2016 - 06/2010
2	Disease Progression 01/2015 - 03/2011
2	Ductal Carcinoma 06/2010 - 02/2009
1	Leiomyosarcoma 11/2022
1	Carcinogenesis 11/2022
1	Starvation 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2021
1	Turcot syndrome 10/2021
1	Ovarian Neoplasms (Ovarian Cancer) 05/2021
1	Intraductal Papilloma 01/2020
1	Vulvar Neoplasms (Vulvar Cancer) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 10/2017
1	Hepatocellular Carcinoma (Hepatoma) 10/2017

Drug/Important Bio-Agent (IBA)

30	Estrogen ReceptorsIBA 01/2021 - 01/2005
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
16	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2005
12	Hormones (Hormone)IBA 01/2022 - 07/2008
10	Phenobarbital (Luminal)FDA Link 10/2011 - 01/2008
8	AntibodiesIBA 01/2020 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2009
6	ErbB Receptors (EGF Receptor)IBA 04/2020 - 08/2005
6	ParaffinIBA 01/2017 - 12/2004
6	Formaldehyde (Formol)FDA Link 01/2017 - 12/2004
6	Keratins (Keratin)IBA 07/2014 - 01/2005
5	Estrogens (Estrogen)FDA Link 01/2017 - 10/2008
3	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2016
3	CollagenIBA 02/2019 - 07/2011
3	Biological ProductsIBA 01/2019 - 03/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2012
3	VimentinIBA 01/2017 - 11/2006
3	Trastuzumab (Herceptin)FDA Link 10/2013 - 02/2010
3	Cadherins (E-Cadherin)IBA 07/2012 - 03/2007
2	somatotropin releasing hormone receptorIBA 11/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2020 - 04/2006
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2009
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2016
2	Long Noncoding RNAIBA 01/2020 - 11/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 03/2011
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 01/2017
2	Insulin-Like PeptidesIBA 01/2017 - 05/2011
2	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 02/2010
2	Messenger RNA (mRNA)IBA 01/2017 - 08/2005
2	LigandsIBA 11/2016 - 05/2011
2	MucinsIBA 06/2016 - 06/2010
2	Combined Antibody TherapeuticsIBA 02/2016 - 01/2007
2	human ERBB2 proteinIBA 10/2011 - 05/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011 - 08/2005
2	2,4,5-trimethoxyphenylisopropylamine (TMA-2)IBA 11/2009 - 11/2008
1	Prolactin Receptors (Prolactin Receptor)IBA 11/2022
1	Coenzyme A (CoA)IBA 01/2022
1	TensinsIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Sincalide FDA Link 01/2022
1	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	C.I. direct red 80IBA 12/2021
1	Coloring Agents (Dyes)IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 10/2021
1	ChemokinesIBA 01/2021
1	CytokinesIBA 01/2021
1	SOX9 Transcription FactorIBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 11/2018
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2018
1	LipidsIBA 04/2018
1	GlycogenIBA 04/2018
1	RetinoidsIBA 04/2018
1	Canertinib (CI 1033)IBA 10/2017
1	MannosidasesIBA 10/2017
1	Protein Sorting Signals (Signal Peptide)IBA 10/2017
1	ChromatinIBA 10/2017
1	proto-oncogene protein c-fes-fpsIBA 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017

Therapy/Procedure

19	Neoadjuvant Therapy 04/2022 - 01/2009
15	Therapeutics 01/2022 - 05/2004
11	Drug Therapy (Chemotherapy) 11/2022 - 05/2004
4	Segmental Mastectomy (Lumpectomy) 01/2019 - 12/2009
4	Mastectomy (Mammectomy) 04/2016 - 01/2009
2	Precision Medicine 01/2022 - 06/2015
2	Radiotherapy 10/2016 - 04/2016
2	Lasers (Laser) 10/2013 - 03/2011
1	Continuity of Patient Care 01/2022
1	Heart-Assist Devices 12/2021
1	Vulvectomy 01/2019
1	Salpingo-oophorectomy 03/2018